Company
Progentos Therapeutics
| Industry | biotech company addressing the need to regenerate myelin and restore function for patients with Multiple Sclerosis (MS) and other demyelinating diseases |
|---|
Funding raised
| Company | Round | Date |
|---|---|---|
| Progentos Therapeutics | series a | 2024-05-20 |